LEGEND BIOTECH CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.92 USD | -6.28% |
|
-14.52% | -34.13% |
| May. 22 | MaxCyte inks deal with Legend Biotech for tech supply | AN |
| May. 22 | MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORPORATION | Bio Therapeutic Drugs | -6.98% | -14.52% | -34.13% | -40.43% | - | 7.77B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation
- Comparison Chart
